Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Simpson-Golabi-Behmel syndrome 1Recurrence 1Hepatoblastoma 1

Interventions

fludarabine 2Cyclophosphamide 2talazoparib 1sodium thiosulfate 1irinotecan sucrosofate 1fludarabine phosphate 1codrituzumab 1X-Rays 1Whole-Body Irradiation 1Vorinostat 1Vincristine 1Transplantation 1Temozolomide 1Tacrolimus 1Specimen Handling 1Phantoms, Imaging 1Nivolumab 1Mesna 1Melphalan 1Influenza Vaccines 1Honey 1Fluorouracil 1Doxorubicin 1Cisplatin 1Carboplatin 1Bone Density 1Biopsy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hepatoblastoma × codrituzumab × Clear all
NCT04928677 2026-02-17

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
50 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Recurrence, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡